Patient Square Capital’s uniQure QURE Stock Holding History

Patient Square Capital’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-75,000	Closed	-$4.38M	–	33
2025 Q3	$4.38M	Buy	+75,000	New	+$1.36M	1.17%	17

Other funds holding QURE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Patient Square Capital's QURE Position: Q4 2025 in Review

Patient Square Capital sold out of uniQure (QURE) in Q4 2025, closing a stake of 75,000 shares — an estimated $4.38M sold.

Patient Square Capital first reported a position in QURE in Q3 2025 and held it in 1 quarter. The position peaked at $4.38M in Q3 2025. 224 funds tracked by Wall St. Rank hold QURE as of Q4 2025.

Patient Square Capital reported no remaining uniQure position as of Q4 2025 after selling out during the quarter.
Patient Square Capital sold 75,000 uniQure shares in Q4 2025, an estimated $4.38M.
Patient Square Capital first reported a position in uniQure in Q3 2025 and held it in 1 quarter.
Patient Square Capital's uniQure position peaked at $4.38M in Q3 2025.
224 funds tracked by Wall St. Rank held uniQure as of Q4 2025.

Based on Patient Square Capital's 13F filing for Q4 2025, filed 12 Feb 2026.